"Performance" DAWNRAYS PHARMA's mid-term net profit is 105 million RMB, down 78.8%, with a dividend of 1.5 HK cents

阿斯达克财经网
2025.08.24 13:37
东瑞制药 (02348.HK) 公布 6 月止六个月中期业绩，收入 6.3 亿人民币 (下同)，按年下降 9.2%。录得纯利 1.05 亿元，倒退 78.8%，每股盈利 6.961 分。中期息维持派 1.5 港仙。
Source: 阿斯达克财经网 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.